A Bibliometric Review of Time in Range Publications and Clinical Trials: Analyzing Trends

A Bibliometric Review of Time in Range Publications and Clinical Trials: Analyzing Trends

A Bibliometric Review of Time in Range Publications and Clinical Trials: Analyzing Trends

[youtubomatic_search]

Key Takeaways

  • The number of publications and clinical trials focusing on Time in Range (TIR) has significantly increased over the past decade.
  • There is a growing recognition of TIR as a critical metric in diabetes management.
  • Most of the research on TIR is concentrated in developed countries, with the United States leading the way.
  • There is a need for more research on TIR in low and middle-income countries.
  • Future trends indicate a continued focus on TIR, with an emphasis on personalized medicine and digital health technologies.

Introduction: The Rising Importance of Time in Range

Time in Range (TIR) is a term used in diabetes management to refer to the percentage of time that a person’s blood glucose levels are within the target range. Over the past decade, there has been a significant increase in the number of publications and clinical trials focusing on TIR, reflecting its growing importance in diabetes care. This article provides a bibliometric review of these publications and trials, analyzing the trends and highlighting key insights.

Increasing Focus on Time in Range

According to a study published in the Journal of Diabetes Science and Technology, the number of publications on TIR has increased exponentially over the past decade. In 2010, there were less than 10 publications on TIR. By 2020, this number had increased to over 200. This trend is mirrored in the number of clinical trials focusing on TIR, which has also seen a significant increase.

Geographical Distribution of Research

Most of the research on TIR is concentrated in developed countries. The United States leads the way, with over 50% of all TIR publications originating from this country. Other countries with a significant number of TIR publications include the United Kingdom, Germany, and Canada. However, there is a notable lack of research from low and middle-income countries, highlighting a need for more inclusive research practices.

Looking ahead, the focus on TIR is expected to continue, with an emphasis on personalized medicine and digital health technologies. Personalized medicine refers to the tailoring of medical treatment to the individual characteristics of each patient. In the context of TIR, this could involve developing personalized target ranges based on a patient’s specific needs and circumstances. Digital health technologies, such as continuous glucose monitors and insulin pumps, are also expected to play a key role in facilitating TIR management.

FAQ Section

What is Time in Range?

Time in Range (TIR) refers to the percentage of time that a person’s blood glucose levels are within the target range.

Why is Time in Range important?

TIR is a critical metric in diabetes management. It provides a more comprehensive picture of a person’s blood glucose control than traditional metrics such as HbA1c.

How has the focus on Time in Range changed over time?

Over the past decade, there has been a significant increase in the number of publications and clinical trials focusing on TIR, reflecting its growing importance in diabetes care.

Which countries are leading the research on Time in Range?

The United States leads the way in TIR research, with over 50% of all TIR publications originating from this country. Other countries with a significant number of TIR publications include the United Kingdom, Germany, and Canada.

Future trends indicate a continued focus on TIR, with an emphasis on personalized medicine and digital health technologies.

Conclusion: The Growing Importance of Time in Range

The increasing number of publications and clinical trials focusing on Time in Range (TIR) underscores its growing importance in diabetes management. While most of the research is concentrated in developed countries, there is a need for more inclusive research practices. Looking ahead, the focus on TIR is expected to continue, with an emphasis on personalized medicine and digital health technologies. As our understanding of TIR continues to evolve, it will play an increasingly critical role in improving the lives of people with diabetes.

[youtubomatic_search]

Further Analysis

  • The number of publications and clinical trials focusing on Time in Range (TIR) has significantly increased over the past decade.
  • There is a growing recognition of TIR as a critical metric in diabetes management.
  • Most of the research on TIR is concentrated in developed countries, with the United States leading the way.
  • There is a need for more research on TIR in low and middle-income countries.
  • Future trends indicate a continued focus on TIR, with an emphasis on personalized medicine and digital health technologies.

We will be happy to hear your thoughts

Leave a reply

Diabetes Compass
Logo
Compare items
  • Cameras (0)
  • Phones (0)
Compare